Stock Split Announced by TNF Pharmaceuticals Amid Nasdaq Compliance Push
TNF Pharmaceuticals has officially announced a reverse stock split as part of its ongoing efforts to meet Nasdaq listing compliance. This move is seen as a critical step to maintain its presence on the exchange and to reassure investors about the company’s long term growth strategy. The announcement has already created strong discussions in the market about what it could mean for shareholders and the future of the company.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
